Clinical Trial Update: Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating performance and safety of Restylane Lidocaine for treatment of depressed facial acne scars has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne - Facial Scar-related Condition
• Depressed Facial Acne Scars

Drugs mentioned

• Restylane Lidocaine (restylane lidocaine)

Snippet

Sponsor: Galderma R&D | Conditions: Healthy Volunteers | Phase 4 | Status: COMPLETED | Results posted: 2019-10-03